Why the study?
Primary cardiac lymphoma carries a poor prognosis and risk of sudden cardiac death, making prompt diagnosis and early treatment essential.
Pericardial effusion cytology is a safe and effective method for the prompt diagnosis of primary cardiac lymphoma.
May aid early cardiac lymphoma diagnosis in select cases; leaves open generalizability and safety confirmation.
Primary cardiac lymphoma is a rare condition with a poor prognosis, and patients are at risk for sudden cardiac death. A prompt diagnosis and early treatment are therefore essential. A 68-year-old woman was admitted for shortness of breath and peripheral edema. Echocardiograms showed massive pericardial effusion and a mass on the free wall of the right atrium and ventricle. Subsequent pericardial effusion cytology revealed diffuse large B-cell lymphoma. We started chemotherapy with rituximab and achieved a good clinical course. This case is made unique by the use of pericardial effusion cytology, which allowed us to diagnose primary cardiac lymphoma promptly and safely.
No takes yet. Share an insight, caveat, or question.
Fukuzaki et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: